REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmvet (M) Sdn Bhd (Malaysia)

Main Activities: Pharmacies and Drug Stores | Veterinary Services
Full name: Pharmvet (M) Sdn Bhd Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Pharmvet (M) Sdn Bhd is a company based in Malaysia, with its head office in Seri Kembangan. It operates in the Pharmacies and Drug Stores industry. It was incorporated on September 01, 1984. From the latest financial highlights, Pharmvet (M) Sdn Bhd reported a net sales revenue increase of 0.84% in 2023. Its’ total assets recorded a growth of 6.15%. In 2023, Pharmvet (M) Sdn Bhd’s net profit margin increased by 1.02%.

Headquarters
No. 12A, Jalan 6/2B, Taman Perindustrian Selesa Jaya
Seri Kembangan; Selangor; Postal Code: 43300

Contact Details: Purchase the Pharmvet (M) Sdn Bhd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharmvet (M) Sdn Bhd report to view the information.
Registered Capital:
Purchase the Pharmvet (M) Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Pharmvet (M) Sdn Bhd report to view the information.
Incorporation Date:
September 01, 1984
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Subsidiaries
Trinitas Global Sdn. Bhd.
70%
Company Performance
Financial values in the chart are available after Pharmvet (M) Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
0.84%
Total operating revenue
0.84%
Operating profit (EBIT)
49.14%
Net Profit (Loss) for the Period
39%
Total assets
6.15%
Total equity
6.41%
Operating Profit Margin (ROS)
1.71%
Net Profit Margin
1.02%
Return on Equity (ROE)
1.62%
Quick Ratio
-0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?